| 000 | 01514 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515062013.0 | ||
| 264 | 0 | _c20070718 | |
| 008 | 200707s 0 0 eng d | ||
| 022 | _a0926-9959 | ||
| 024 | 7 |
_a10.1111/j.1468-3083.2006.01949.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBachmeyer, C | |
| 245 | 0 | 0 |
_aGranulomatous tattoo reaction in a patient treated with etanercept. _h[electronic resource] |
| 260 |
_bJournal of the European Academy of Dermatology and Venereology : JEADV _cApr 2007 |
||
| 300 |
_a550-2 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadverse effects |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xadverse effects |
| 650 | 0 | 4 | _aCausality |
| 650 | 0 | 4 |
_aDrug Eruptions _xetiology |
| 650 | 0 | 4 | _aEtanercept |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGranuloma _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aReceptors, Tumor Necrosis Factor |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTattooing |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aBlum, L | |
| 700 | 1 | _aPetitjean, B | |
| 700 | 1 | _aKemiche, F | |
| 700 | 1 | _aPertuiset, E | |
| 773 | 0 |
_tJournal of the European Academy of Dermatology and Venereology : JEADV _gvol. 21 _gno. 4 _gp. 550-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1468-3083.2006.01949.x _zAvailable from publisher's website |
| 999 |
_c16928879 _d16928879 |
||